公告日期：2025-04-28

亿帆医药:2024年度环境、社会和公司治理(ESG)报告(英文版)
Report Introduction
This report is based on Yifan Pharmaceutical Co.,Ltd.（hereinafter referred to as “Yifan
Pharmaceutical”，the “Company”，or “we” ）.aimed at presenting to stakeholders the concepts
upheld，management approaches adopted，work progress made，and results achieved by the
Company in the areas of environment， societyand corporate governance in the year 2024.
Basis of Report Preparation
In accordance with the GRI Sustainability Reporting Standards issued by the Global Sustainability
Standards Board （GSSB）
International Organization for Standardization （ISO） “ISO26000:Guidance on Social Responsibility
（2010）and other international requirements
With reference to the national standard GB/T 36001-2015-Guidelines for the Preparation of
Social Responsibility Reports
With reference to the United Nations Sustainable Development Goals(SDGs）
Prepared in accordance with the Guidelines No.17for Self-Regulation of Listed Companies
Sustainable Development Reports (Trial） issued by the Shenzhen Stock Exchange
……

[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。